Praxis Precision Medicines Inc (PRAX)
EBITDA Growth
-17.73%
Quarterly · Period ending:
PRAX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-17.73%period ending
Latest reported-17.73%period ending
PRAX Quarterly EBITDA YoY % (4.01% → -17.73%)
Year-over-year change
High-resolution chart · PNG
PRAX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -17.7347% | |
| -33.6077% | |
| -51.5947% | |
| -42.6435% | |
| -118.2407% | |
| -75.5762% | |
| -119.9167% | |
| -111.3037% | |
| 4.7828% | |
| -5.6012% | |
| 33.9224% | |
| 44.0663% | |
| 42.2927% | |
| 45.5744% | |
| 31.022% | |
| 1.8316% | |
| -62.9598% | |
| -150.4891% | |
| -127.674% | |
| -175.5661% | |
| -214.654% | |
| -223.8681% | |
| -243.2924% | |
| -52.2642% | |
| -31.1847% | |
| 4.0059% |